Ausejo M, Saenz A, Pham B, Kellner J D, Johnson D W, Moher D, Klassen T P
Thomas C Chalmer's Center for Systematic Reviews, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, Ontario K1H 8LI, Canada.
BMJ. 1999 Sep 4;319(7210):595-600. doi: 10.1136/bmj.319.7210.595.
To determine the effectiveness of glucocorticoid treatment in children with croup.
Meta-analysis of randomised controlled trials that examine the effectiveness of glucocorticoid treatment in children with croup.
Score on scale measuring severity of croup, use of cointerventions (adrenaline (epinephrine), antibiotics, or supplemental glucocorticoids), length of stay in accident and emergency or in hospital, and rate of hospitalisation.
Twenty four studies met the inclusion criteria. Glucocorticoid treatment was associated with an improvement in the croup severity score at 6 hours with an effect size of -1.0 (95% confidence interval -1.5 to -0.6) and at 12 hours -1.0 (-1.6 to -0.4); at 24 hours this improvement was no longer significant (-1.0, -2.0 to 0.1). There was a decrease in the number of adrenaline treatments needed in children treated with glucocorticoids: a decrease of 9% (95% confidence interval 2% to 16%) among those treated with budesonide and of 12% (4% to 20%) among those treated with dexamethasone. There was also a decrease in the length of time spent in accident and emergency (-11 hours, 95% confidence interval -18 to 4 hours), and for inpatients hospital stay was reduced by 16 hours (-31 to 1 hour). Publication bias seems to play a part in these results.
Dexamethasone and budesonide are effective in relieving the symptoms of croup as early as 6 hours after treatment. Fewer cointerventions are used and the length of time spent in hospital is decreased in patients treated with glucocorticoids.
确定糖皮质激素治疗小儿喉炎的有效性。
对研究糖皮质激素治疗小儿喉炎有效性的随机对照试验进行荟萃分析。
喉炎严重程度量表评分、辅助干预措施(肾上腺素、抗生素或补充糖皮质激素)的使用情况、急诊或住院时间以及住院率。
24项研究符合纳入标准。糖皮质激素治疗与6小时时喉炎严重程度评分改善相关,效应量为-1.0(95%置信区间-1.5至-0.6),12小时时为-1.0(-1.6至-0.4);24小时时这种改善不再显著(-1.0,-2.0至0.1)。接受糖皮质激素治疗的儿童所需肾上腺素治疗次数减少:布地奈德治疗者减少9%(95%置信区间2%至16%),地塞米松治疗者减少12%(4%至20%)。急诊停留时间也减少(-11小时,95%置信区间-18至4小时),住院患者住院时间减少16小时(-31至1小时)。发表偏倚似乎对这些结果有影响。
地塞米松和布地奈德在治疗后6小时即可有效缓解喉炎症状。接受糖皮质激素治疗的患者辅助干预措施使用较少,住院时间缩短。